Skip to main content
Donate
Login
Celebrate IASLC's 50th Anniversary
Celebrate IASLC's 50th Anniversary
History
Support The Mission
Support The Mission
Partners for Thoracic Cancer Care
Legacy Society
IASLC Global Member Survey on Inclusivity
Learn About Us
Learn About Us
Strategic Plan
Board of Directors
Committees
Awards
Staff
Contact
Search
Donate
Login
Conferences & Webinars
Conferences & Webinars
Upcoming Conferences & Webinars
Past Conferences & Webinars
WCLC 2024
Research & Education
Research & Education
Publications, Resources & Guidelines
Journals
Journals
Journal of Thoracic Oncology
JTO Clinical and Research Reports (JTO CRR)
IASLC Reviewer Workshop
Lung Cancer 360
Research Projects
Research Projects
Staging Project
IASLC Global Survey on Biomarker Testing in Lung Cancer 2024 Update
IASLC Neoadjuvant Therapy in Lung Cancers Initiatives
IASLC Atlas of Molecular Testing for Targeted Therapy in Lung Cancer
ELIC
Early-Career Opportunities
News
News
ILCN
Press Releases
Lung Cancer Considered Podcast
Membership
Membership
Become a Member
Renew Your Membership
Partner Society Membership Offers
Patient Advocacy
Patient Advocacy
STARS
Advocacy Partner Spotlight
Lung Cancer Awareness Month 2023 Highlights
Foundation
Foundation
Donor Recognition
Research Grant Program
Grant Recipient Spotlights
Research Grant Recipients
Search
Fulltext search
Fulltext search
Search
Displaying 97 - 108 items out of 264 results
ILCN article
Smoking Ban in Austria Passed After Years of Political Wrangling
ILCN article
Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint Blockage in NSCLC
ILCN article
Lung Cancer Leading the Charge for Tumor-Agnostic Targeted Therapies
ILCN article
Experts Discuss Turnaround Times, Geographic Differences Regarding Liquid Biopsy
ILCN article
Concurrent Chemoradiation Followed by Consolidation Therapy: Questions Remain Despite Transformational Data
ILCN article
Key Findings from the CAR T-Cell Study Presented at the 2019 AACR Annual Meeting
ILCN article
Adjuvant EGFR-TKI for Resected NSCLC: Who, When, and Where?
ILCN article
Antibody–Drug Conjugates in NSCLC: Complexities, Challenges, and Potential
ILCN article
Consolidating Gains with Chemotherapy in SCLC Maintenance Trials: A Discussion with Dr. Shirish Gadgeel
ILCN article
Tackling TKI-Refractory Disease in Patients with Oncogenic Drivers: An Interview with Dr. Mark Socinski
ILCN article
Making Headway with Lorlatinib
ILCN article
Clinical Utility of Plasma Next-Generation Sequencing in Advanced NSCLC: Are We Ready for a ‘Blood-First’ Approach?
Pagination
First
First page
‹
Previous page
…
5
6
7
8
9
10
11
12
13
…
›
Next page
Last
Last page